X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs DR. DATSONS LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES DR. DATSONS LABS SUVEN LIFESCIENCES/
DR. DATSONS LABS
 
P/E (TTM) x 17.6 -10.9 - View Chart
P/BV x 3.6 0.2 2,201.8% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 SUVEN LIFESCIENCES   DR. DATSONS LABS
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
DR. DATSONS LABS
Mar-14
SUVEN LIFESCIENCES/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs338126 268.9%   
Low Rs16931 548.2%   
Sales per share (Unadj.) Rs52.1133.0 39.2%  
Earnings per share (Unadj.) Rs6.80.2 4,505.4%  
Cash flow per share (Unadj.) Rs8.66.6 129.7%  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs65.3128.8 50.7%  
Shares outstanding (eoy) m127.2831.66 402.0%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x4.90.6 826.6%   
Avg P/E ratio x37.1516.1 7.2%  
P/CF ratio (eoy) x29.611.8 249.8%  
Price / Book Value ratio x3.90.6 639.2%  
Dividend payout %22.00-   
Avg Mkt Cap Rs m32,2722,477 1,302.7%   
No. of employees `0001.1NA-   
Total wages/salary Rs m66156 1,180.7%   
Avg. sales/employee Rs Th6,132.2NM-  
Avg. wages/employee Rs Th611.1NM-  
Avg. net profit/employee Rs Th803.5NM-  
INCOME DATA
Net Sales Rs m6,6354,211 157.6%  
Other income Rs m24279 307.9%   
Total revenues Rs m6,8774,289 160.3%   
Gross profit Rs m1,604569 282.1%  
Depreciation Rs m221204 108.3%   
Interest Rs m38430 8.8%   
Profit before tax Rs m1,58713 12,499.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7186 11,770.3%   
Profit after tax Rs m8695 18,112.7%  
Gross profit margin %24.213.5 179.0%  
Effective tax rate %45.248.0 94.2%   
Net profit margin %13.10.1 11,494.1%  
BALANCE SHEET DATA
Current assets Rs m6,2326,852 91.0%   
Current liabilities Rs m1,4906,711 22.2%   
Net working cap to sales %71.53.3 2,134.2%  
Current ratio x4.21.0 409.6%  
Inventory Days Days86161 53.7%  
Debtors Days Days83318 25.9%  
Net fixed assets Rs m4,0433,673 110.1%   
Share capital Rs m127317 40.2%   
"Free" reserves Rs m8,1833,761 217.6%   
Net worth Rs m8,3104,078 203.8%   
Long term debt Rs m181,671 1.1%   
Total assets Rs m10,38912,633 82.2%  
Interest coverage x43.11.0 4,187.0%   
Debt to equity ratio x00.4 0.5%  
Sales to assets ratio x0.60.3 191.6%   
Return on assets %8.73.4 253.6%  
Return on equity %10.50.1 8,887.5%  
Return on capital %19.57.7 254.3%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m5,622964 583.2%   
Fx outflow Rs m1,799607 296.4%   
Net fx Rs m3,822357 1,071.0%   
CASH FLOW
From Operations Rs m3561,345 26.4%  
From Investments Rs m-279-2,256 12.4%  
From Financial Activity Rs m-225-1,200 18.8%  
Net Cashflow Rs m-148-2,111 7.0%  

Share Holding

Indian Promoters % 63.4 4.5 1,399.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 1.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 94.1 38.8%  
Shareholders   37,287 20,807 179.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   PROCTER & GAMBLE HEALTH  CIPLA  TORRENT PHARMA  ALEMBIC LTD  WYETH LTD  

Compare SUVEN LIFESCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 267 Points Lower; Metal and Capital Goods Stocks Witness Huge Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 267 points (down 0.7%).

Related Views on News

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

More Views on News

Most Popular

The Perfect Stock in the Rebirth of India(The 5 Minute Wrapup)

Aug 8, 2019

This debt-free, well-managed company is all set to soar.

This 60-Year Old Smallcap Company Could Be Our Next Recommendation(The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Super investor Pulak Prasad is Buying Stocks Big Time...and You Should Too(The 5 Minute Wrapup)

Aug 9, 2019

Here's why the relentless correction in the Indian stock markets has not unnerved the big investors.

Smallcaps that Will Outperform in the Market Rebound(Profit Hunter)

Aug 12, 2019

Only These Smallcaps Will Give Historic Returns in the Future.

Qatar is Rearing Cows...this is Good News for India

Aug 9, 2019

Qatar has turned around after the Saudi embargo. This is good news for India.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Aug 21, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 5-YR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS